WallStreetZenWallStreetZen

NYSE: THC
Tenet Healthcare Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for THC

Based on 16 analysts offering 12 month price targets for Tenet Healthcare Corp

Min Forecast
$224.00-2.57%
Avg Forecast
$248.44+8.06%
Max Forecast
$288.00+25.27%

Should I buy or sell THC stock?

Based on 16 analysts offering ratings for Tenet Healthcare Corp.

Strong Buy
Strong Buy
13 analysts 81.25%
Buy
3 analysts 18.75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their THC stock forecasts and price targets.

THC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-20
lockedlocked$00.00+00.00%2026-02-17Find Out Why
lockedlocked$00.00+00.00%2026-02-13
lockedlocked$00.00+00.00%2026-02-13
lockedlocked$00.00+00.00%2026-02-12
RBC Capital
Top 14%
87
BuyMaintains$277.00+20.49%2026-02-12
UBS
Top 10%
91
Strong BuyMaintains$288.00+25.27%2026-02-12Find out why
KeyBanc
Top 17%
84
Strong BuyMaintains$250.00+8.74%2026-02-12Find out why
Wells Fargo
Bottom 20%
20
Strong BuyMaintains$229.00-0.39%2026-01-07
TD Cowen
Bottom 11%
11
Strong BuyMaintains$230.00+0.04%2026-01-07

1 of 2

Forecast return on equity

Is THC forecast to generate an efficient return?

Company
43.71%
Industry
-106.7%
Market
236.88%
THC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is THC forecast to generate an efficient return on assets?

Company
6.22%
Industry
12.81%
THC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

THC earnings per share forecast

What is THC's earnings per share in the next 3 years based on estimates from 23 analysts?

Avg 1 year Forecast
$16.61+6.38%
Avg 2 year Forecast
$17.97+15.09%
Avg 3 year Forecast
$20.52+31.44%
THC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

THC revenue forecast

What is THC's revenue in the next 3 years based on estimates from 23 analysts?

Avg 1 year Forecast
$22.3B+4.8%
Avg 2 year Forecast
$22.9B+7.35%
Avg 3 year Forecast
$23.8B+11.73%
THC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

THC earnings growth forecast

How is THC forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
8.32%
Industry
14.72%
Market
39.25%
THC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
THC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
THC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

THC revenue growth forecast

How is THC forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
3.55%
Industry
4.71%
Market
23.93%
THC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
THC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

THC vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
THC$229.90$248.44+8.06%Strong Buy
UHS$230.49$252.25+9.44%Buy
FMS$24.38N/AN/A
ENSG$210.64$214.25+1.71%Strong Buy
EHC$106.55$150.75+41.48%Strong Buy
View Top Medical Care Facility Stocks

Tenet Healthcare Stock Forecast FAQ

Is Tenet Healthcare Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 16 Wall Street analysts covering (NYSE: THC) stock is to Strong Buy THC stock.

Out of 16 analysts, 13 (81.25%) are recommending THC as a Strong Buy, 3 (18.75%) are recommending THC as a Buy, 0 (0%) are recommending THC as a Hold, 0 (0%) are recommending THC as a Sell, and 0 (0%) are recommending THC as a Strong Sell.

If you're new to stock investing, here's how to buy Tenet Healthcare stock.

What is THC's earnings growth forecast for 2026-2028?

(NYSE: THC) Tenet Healthcare's forecast annual earnings growth rate of 8.32% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 14.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.25%.

Tenet Healthcare's earnings in 2026 is $1,407,000,000.On average, 23 Wall Street analysts forecast THC's earnings for 2026 to be $1,444,151,060, with the lowest THC earnings forecast at $1,210,177,108, and the highest THC earnings forecast at $1,625,338,470. On average, 19 Wall Street analysts forecast THC's earnings for 2027 to be $1,562,385,954, with the lowest THC earnings forecast at $1,216,142,770, and the highest THC earnings forecast at $1,849,050,788.

In 2028, THC is forecast to generate $1,784,324,227 in earnings, with the lowest earnings forecast at $1,474,370,702 and the highest earnings forecast at $2,130,289,130.

What is THC's revenue growth forecast for 2026-2028?

(NYSE: THC) Tenet Healthcare's forecast annual revenue growth rate of 3.55% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.93%.

Tenet Healthcare's revenue in 2026 is $21,310,000,000.On average, 23 Wall Street analysts forecast THC's revenue for 2026 to be $1,942,057,716,000, with the lowest THC revenue forecast at $1,860,051,607,000, and the highest THC revenue forecast at $2,099,721,635,000. On average, 22 Wall Street analysts forecast THC's revenue for 2027 to be $1,989,452,551,000, with the lowest THC revenue forecast at $1,843,180,785,000, and the highest THC revenue forecast at $2,166,422,256,000.

In 2028, THC is forecast to generate $2,070,502,067,000 in revenue, with the lowest revenue forecast at $1,938,753,122,000 and the highest revenue forecast at $2,203,642,420,000.

What is THC's forecast return on assets (ROA) for 2026-2029?

(NYSE: THC) forecast ROA is 6.22%, which is lower than the forecast US Medical Care Facilities industry average of 12.81%.

What is THC's Price Target?

According to 16 Wall Street analysts that have issued a 1 year THC price target, the average THC price target is $248.44, with the highest THC stock price forecast at $288.00 and the lowest THC stock price forecast at $224.00.

On average, Wall Street analysts predict that Tenet Healthcare's share price could reach $248.44 by Feb 20, 2027. The average Tenet Healthcare stock price prediction forecasts a potential upside of 8.06% from the current THC share price of $229.90.

What is THC's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: THC) Tenet Healthcare's current Earnings Per Share (EPS) is $15.61. On average, analysts forecast that THC's EPS will be $16.61 for 2026, with the lowest EPS forecast at $13.92, and the highest EPS forecast at $18.69. On average, analysts forecast that THC's EPS will be $17.97 for 2027, with the lowest EPS forecast at $13.98, and the highest EPS forecast at $21.26. In 2028, THC's EPS is forecast to hit $20.52 (min: $16.95, max: $24.50).

What is THC's forecast return on equity (ROE) for 2026-2029?

(NYSE: THC) forecast ROE is 43.71%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.